Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 09:01 am Sale | 2024-09-30 | 13G | Nuo Therapeutics, Inc. AURX | James E. Flynn | 1,026,324 2.200% | -1,156,840 (-52.99%) | Filing History |
| 2024-11-14 09:00 am Sale | 2024-09-30 | 13G | HilleVax, Inc. HLVX | James E. Flynn | 1,882,654 3.780% | -2,121,577 (-52.98%) | Filing History |
| 2024-11-14 08:59 am Sale | 2024-09-30 | 13G | Edgewise Therapeutics, Inc. EWTX | James E. Flynn | 1,781,006 1.900% | -2,697,586 (-60.23%) | Filing History |
| 2024-11-14 08:57 am Purchase | 2024-09-30 | 13G | Ventyx Biosciences, Inc. VTYX | James E. Flynn | 6,715,501 9.500% | 3,173,501 (+89.60%) | Filing History |
| 2024-11-14 08:56 am Sale | 2024-09-30 | 13G | Solid Biosciences Inc. SLDB | James E. Flynn | 0 0.000% | -2,260,398 (Position Closed) | Filing History |
| 2024-11-14 08:55 am Sale | 2024-09-30 | 13G | Nkarta, Inc. NKTX | James E. Flynn | 2,155,000 3.050% | -1,245,000 (-36.62%) | Filing History |
| 2024-11-14 08:54 am Purchase | 2024-09-30 | 13G | Merus N.V. MRUS | James E. Flynn | 3,408,539 4.980% | 388,638 (+12.87%) | Filing History |
| 2024-11-14 08:54 am Purchase | 2024-09-30 | 13G | MALLINCKRODT PLC SHS MNKTQ | James E. Flynn | 1,460,233 7.410% | 179,000 (+13.97%) | Filing History |
| 2024-11-14 08:53 am Unchanged | 2024-09-30 | 13G | Windtree Therapeutics, Inc. WINT | James E. Flynn | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-11-12 6:58 pm Purchase | 2024-11-06 | 13G | Oscar Health, Inc. OSCR | James E. Flynn | 11,835,000 5.590% | 588,180 (+5.23%) | Filing History |
| 2024-11-08 4:49 pm Purchase | 2024-11-01 | 13G | Lomond Therapeutics Holdings, Inc. | James E. Flynn | 2,692,625 9.900% | 2,692,625 (New Position) | Filing History |
| 2024-11-01 7:54 pm Unchanged | 2024-10-31 | 13D | Singular Genomics Systems, Inc. OMIC | James E. Flynn | 249,495 6.660% | 0 (Unchanged) | Filing History |
| 2024-10-25 5:45 pm Purchase | 2024-10-18 | 13G | Embecta Corp. EMBC | James E. Flynn | 3,075,335 5.330% | 3,075,335 (New Position) | Filing History |
| 2024-09-20 6:00 pm Purchase | 2024-09-13 | 13G | Foghorn Therapeutics Inc. FHTX | James E. Flynn | 2,935,295 5.310% | 2,935,295 (New Position) | Filing History |
| 2024-09-12 4:07 pm Purchase | 2024-09-05 | 13D | Singular Genomics Systems, Inc. OMIC | James E. Flynn | 249,495 6.660% | 249,495 (New Position) | Filing History |
| 2024-07-11 6:47 pm Purchase | 2024-07-09 | 13D | BiomX Inc. PHGE | James E. Flynn | 15,558,445 9.990% | 14,947,435 (+2446.35%) | Filing History |
| 2024-05-30 7:26 pm Unchanged | 2024-05-30 | 13D | BiomX Inc. PHGE | James E. Flynn | 611,010 8.750% | 0 (Unchanged) | Filing History |
| 2024-05-17 5:14 pm Purchase | 2024-05-07 | 13G | Alignment Healthcare, Inc. ALHC | James E. Flynn | 10,865,513 5.680% | 10,865,513 (New Position) | Filing History |
| 2024-05-15 6:39 pm Purchase | 2024-05-15 | 13G | Nuvalent, Inc. NUVL | James E. Flynn | 25,579,890 33.990% | 102,114 (+0.40%) | Filing History |
| 2024-04-24 5:50 pm Purchase | 2024-04-18 | 13G | Cullinan Oncology, Inc. CGEM | James E. Flynn | 3,283,824 5.710% | 3,283,824 (New Position) | Filing History |